Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Merck
Johnson and Johnson
Baxter
Moodys

Last Updated: October 14, 2019

DrugPatentWatch Database Preview

DETROL LA Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Detrol La patents expire, and what generic alternatives are available?

Detrol La is a drug marketed by Pharmacia And Upjohn and is included in one NDA. There are three patents protecting this drug and one Paragraph IV challenge.

This drug has one hundred and thirty-seven patent family members in forty-four countries.

The generic ingredient in DETROL LA is tolterodine tartrate. There are twenty-three drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the tolterodine tartrate profile page.

Drug patent expirations by year for DETROL LA
Drug Prices for DETROL LA

See drug prices for DETROL LA

Drug Sales Revenue Trends for DETROL LA

See drug sales revenues for DETROL LA

Recent Clinical Trials for DETROL LA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of California, San FranciscoPhase 4
Astellas Scientific & Medical Affairs, Inc.N/A
Astellas Pharma Global Development, Inc.Phase 4

See all DETROL LA clinical trials

Recent Litigation for DETROL LA

Identify potential future generic entrants

District Court Litigation
Case NameDate
PFIZER INC. v. LUPIN LTD.2013-03-21
PFIZER INC. v. TEVA PHARMACEUTICALS USA, INC.2008-03-13
Pfizer Inc. v. IMPAX Laboratories, Inc.2008-03-04

See all DETROL LA litigation

Pharmacology for DETROL LA
Synonyms for DETROL LA
(+)-(r)-2-(a-[2-(diisopropylamino)ethyl]benzyl)-p-cresol tartrate
(+)-(R)-2-(I-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol L-tartrate (1:1) (salt)
(+)-r)-2-{a-(2-(diisopropylamino)ethyl)benzyl}-p-cresol tartrate
(2R,3R)-2,3-dihydroxybutanedioic acid,2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-methylphenol
(2R,3R)-2,3-dihydroxybutanedioic acid; 2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-methylphenol
(2R,3R)-2,3-dihydroxybutanedioic acid;2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-methylphenol
(R)-2-(3-(Bis(1-methylethyl)amino)-1-phenylpropyl)-4-methylphenol (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1) (salt)
(R)-2-(3-(diisopropylamino)-1-phenylpropyl)-
(R)-2-(3-(Diisopropylamino)-1-phenylpropyl)-4-methylphenol (2R,3R)-2,3-dihydroxysuccinate
(R)-2-(3-Diisopropylamino-1-phenyl-propyl)-p-cresol L-tartrate
(R)-2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenol L-Tartrate
(R)-2-[3-(Diisopropylamino)-1-phenylpropyl]-4-methylphenolL-Tartrate
(tolterodine tartrate)
124937-52-6
2-[(1R)-3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-methylphenol (2R,3R)-2,3-dihydroxybutanedioate
209747-05-7
4-methylphenol (2R,3R)-2,3-dihydroxysuccinate
5T619TQR3R
937T526
AB2000647
AB42195
AC-2617
AC1L9FDO
AK-72840
AKOS015961803
API0008372
AS-35344
AX8017869
BCP0726000292
C22H31NO.C4H6O6
C26H37NO7
CCG-221263
CS-0441
D01148
Detrol
Detrol (TN)
Detrol LA;Kabi-2234;PNU-200583E
Detrusitol
Detrusitol (TN)
Detrusitol SR
DS-1398
FT-0631119
HMS3715N08
HY-90010
J-500064
Kabi-2234
KS-0000099P
L-tartaric acid; tolterodine
LS-172609
MLS003915640
MolPort-005-935-051
Phenol, 2-((1R)-3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-methyl-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt)
Phenol, 2-(3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-methyl-, (R)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1) (salt)
Phenol,2-((1R)-3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-methyl-,(2R,3R)-2,3-dihydroxybutanedioate
PNU 200583E
PNU-200583E
s2550
SCHEMBL467372
SMR002544692
ST2402599
SW197495-2
Tolterodine L-Tartrate
tolterodine l-tartrate 124937-51-5
Tolterodine L-tartrate, >=98% (HPLC)
Tolterodine tartrate
Tolterodine tartrate (Detrol LA)
Tolterodine tartrate (JAN/USAN)
Tolterodine tartrate [USAN]
Tolterodine Tartrate,(S)
Tolterodine Tartrate|124937-52-6|Kabi-2234|PNU-200583E
tolterodine, tartrate
Tolterodinetartrate
TWHNMSJGYKMTRB-KXYUELECSA-N
UNII-5T619TQR3R
Urotrol

US Patents and Regulatory Information for DETROL LA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-001 Dec 22, 2000 AB RX Yes No   See Pricing   See Pricing Y   See Pricing
Pharmacia And Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-002 Dec 22, 2000 AB RX Yes Yes   See Pricing   See Pricing Y   See Pricing
Pharmacia And Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-001 Dec 22, 2000 AB RX Yes No   See Pricing   See Pricing Y   See Pricing
Pharmacia And Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-001 Dec 22, 2000 AB RX Yes No   See Pricing   See Pricing Y   See Pricing
Pharmacia And Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-002 Dec 22, 2000 AB RX Yes Yes   See Pricing   See Pricing Y   See Pricing
Pharmacia And Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-002 Dec 22, 2000 AB RX Yes Yes   See Pricing   See Pricing Y   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for DETROL LA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-001 Dec 22, 2000   See Pricing   See Pricing
Pharmacia And Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-002 Dec 22, 2000   See Pricing   See Pricing
Pharmacia And Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-001 Dec 22, 2000   See Pricing   See Pricing
Pharmacia And Upjohn DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228-002 Dec 22, 2000   See Pricing   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for DETROL LA
Drugname Dosage Strength RLD Date
➤ Subscribe Extended-release Capsules 2 mg and 4 mg ➤ Subscribe   See Pricing

Supplementary Protection Certificates for DETROL LA

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0325571 C980020 Netherlands   See Pricing PRODUCT NAME: TOLTERODINE, DESGEWENST IN DE VORM VAN EEN ZOUT MET EEN FYSIOLO GISCH ACCEPTABEL ZUUR, IN HET BIJZONDER TOLTERODINE L-TARTRAAT; NAT. REGISTRATION NO/DATE: RVG 22148, RVG 22149 19980217; FIRST REGISTRATION: SE 13475, 13476 19970905
0325571 SPC/GB98/027 United Kingdom   See Pricing PRODUCT NAME: TOLTERODINE OPTIONALLY IN THE FORM OF PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: SE 13475 19970905; SE 13476 19970905; UK 00032/0222 19980203; UK 00032/0223 19980203
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Boehringer Ingelheim
Medtronic
McKesson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.